MADEDDU, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 31.359
AS - Asia 17.374
EU - Europa 11.625
SA - Sud America 10.310
AF - Africa 585
Continente sconosciuto - Info sul continente non disponibili 293
OC - Oceania 73
AN - Antartide 1
Totale 71.620
Nazione #
US - Stati Uniti d'America 30.676
BR - Brasile 9.090
SG - Singapore 6.735
CN - Cina 5.802
UA - Ucraina 4.094
IT - Italia 2.095
DE - Germania 1.519
HK - Hong Kong 1.472
VN - Vietnam 1.360
SE - Svezia 1.209
FR - Francia 823
FI - Finlandia 683
GB - Regno Unito 409
AR - Argentina 397
TR - Turchia 308
BD - Bangladesh 223
EC - Ecuador 217
CA - Canada 215
IQ - Iraq 211
RU - Federazione Russa 198
IN - India 196
MX - Messico 182
UZ - Uzbekistan 174
ZA - Sudafrica 164
CO - Colombia 153
VE - Venezuela 146
MA - Marocco 126
PK - Pakistan 117
JP - Giappone 88
ID - Indonesia 81
PY - Paraguay 78
CL - Cile 75
TN - Tunisia 73
UY - Uruguay 64
AU - Australia 61
JO - Giordania 61
KE - Kenya 60
ES - Italia 58
PE - Perù 58
NL - Olanda 55
BE - Belgio 53
PL - Polonia 53
CZ - Repubblica Ceca 51
AZ - Azerbaigian 50
JM - Giamaica 48
AE - Emirati Arabi Uniti 46
NP - Nepal 46
DZ - Algeria 45
KR - Corea 45
KZ - Kazakistan 44
RO - Romania 43
EU - Europa 42
SA - Arabia Saudita 42
HN - Honduras 40
EG - Egitto 37
DO - Repubblica Dominicana 34
PH - Filippine 31
CR - Costa Rica 29
IL - Israele 28
AT - Austria 27
BO - Bolivia 27
IE - Irlanda 27
AL - Albania 26
GT - Guatemala 26
KG - Kirghizistan 26
PS - Palestinian Territory 25
PA - Panama 24
OM - Oman 23
IR - Iran 22
LT - Lituania 21
SV - El Salvador 21
BY - Bielorussia 20
GE - Georgia 19
LB - Libano 19
NI - Nicaragua 19
SN - Senegal 19
RS - Serbia 18
MK - Macedonia 15
BA - Bosnia-Erzegovina 14
BG - Bulgaria 14
TT - Trinidad e Tobago 14
BH - Bahrain 13
GR - Grecia 12
NZ - Nuova Zelanda 12
BN - Brunei Darussalam 11
CH - Svizzera 11
MD - Moldavia 11
MY - Malesia 11
HU - Ungheria 10
NG - Nigeria 10
AM - Armenia 9
AO - Angola 9
PR - Porto Rico 9
QA - Qatar 9
XK - ???statistics.table.value.countryCode.XK??? 9
SY - Repubblica araba siriana 8
ET - Etiopia 7
HR - Croazia 7
DK - Danimarca 6
EE - Estonia 6
Totale 71.259
Città #
Dallas 8.021
Singapore 3.141
Chandler 2.880
Jacksonville 2.646
San Jose 2.278
Ashburn 1.811
Hong Kong 1.447
Princeton 1.333
Dearborn 1.205
Nanjing 1.136
Council Bluffs 1.123
Santa Clara 888
Beijing 848
Columbus 693
São Paulo 637
Wilmington 628
Lauterbourg 573
Ho Chi Minh City 485
Nanchang 415
Shanghai 400
Milan 385
Boardman 344
New York 336
Hanoi 305
Rio de Janeiro 285
Shenyang 276
Los Angeles 245
Belo Horizonte 244
Hebei 242
Sassari 239
Tianjin 222
Changsha 215
Brasília 182
Jiaxing 180
Tashkent 159
Curitiba 128
Porto Alegre 127
San Francisco 118
Miano 115
Hangzhou 107
Buffalo 104
Ann Arbor 103
Guarulhos 103
Kunming 101
Woodbridge 100
Rome 96
Campinas 91
Norwalk 89
Baghdad 88
Goiânia 88
Munich 88
Tokyo 83
Salvador 82
Johannesburg 76
Guayaquil 75
Izmir 68
Manaus 66
Toronto 66
Chicago 65
Fortaleza 65
Jinan 63
Frankfurt am Main 61
Brooklyn 60
Dhaka 60
Quito 59
São José dos Campos 57
Amman 56
Da Nang 56
Ribeirão Preto 56
Sorocaba 56
Atlanta 55
Montevideo 55
Zhengzhou 55
Haiphong 52
Recife 52
Brussels 51
Nairobi 51
Caxias do Sul 50
Guangzhou 50
São Bernardo do Campo 50
Istanbul 49
Juiz de Fora 47
Baku 46
Bauru 46
Campo Grande 46
Denver 46
Montreal 46
Orem 46
Santo André 46
Betim 45
Phoenix 45
Bogotá 44
Contagem 44
Osasco 44
Uberlândia 44
Chennai 43
Seoul 43
Catania 42
London 42
Joinville 41
Totale 40.739
Nome #
Terapia con CBZ e diaschisi cerebellare crociata 361
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders 297
Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma 287
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 285
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease 283
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 262
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 257
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 253
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia 247
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 247
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 247
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 247
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 245
123I FP-CIT SPECT in early Parkinson’s disease 242
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. 240
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. 235
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 234
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 229
99mTc-Tetrofosmin Pinhole-SPECT (P-SPECT) and Radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 228
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 220
99mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis 220
111In-pentetreotide SPECT/CT for functional anatomical mapping in patients with pulmonary carcinoid. 205
(99mTC)sestamibi and (99mTc)tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors 204
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 197
99mTc-tetrofosmin SPECT: a useful diagnostic tool in breast cancer (BC) detection 196
The value of preoperative molecular breast imaging for the size assessment of invasive carcinoma and ductal carcinoma in situ 195
12. Prolactin (PRL) response to Thyrotropin Releasing Hormone (TRH) in patients with subacute thyroiditis in the early stage. 194
A FOLLOW-UP-STUDY OF SURGICALLY TREATED AUTONOMOUS THYROID-NODULES 188
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 186
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 185
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) 184
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative staging of breast cancer: a comparative study. 179
Breast scintigraphy with breast-specific γ-camera (BSGC) in the detection of ductal carcinoma in situ (DCIS): a correlation with mammography and histologic subtype. 176
The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy 176
99mTc-Tetrofosmin scan in non small cell lung cancer (NSCLC) 174
18F-FDG PET/CT Usefulness In Primary Progressive Aphasia (PPA) Variants And In Fronto-Temporal Dementia (FTD) Or Alzheimer’s Disease (AD) Development. 171
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 168
99mTc-tetrofosmin SPECT/CT in solitary pulmonary nodule (SPN) evaluation. 164
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 163
123I-MIBG Cardiac Scintigraphy and123I-IOFLUPANE SPECT Combined Use In Uncertain Parkinsonian Syndromes 163
Role of an artificial neural network classifier, a classification tree (ClT), to diagnose Parkinson’s disease in early phase by using 123I-FP-CIT brain SPECT data. 163
The value of semiquantitative FDG-PET parameters in the diagnosis of solitary pulmonary nodules with pre-test intermediate likelihood of malignancy: a single-centre study 163
99mTc-Tetrofosmin axillary planar, SPECT and Pinhole SPECT (P-SPECT) in breast cancer (BC) non palpable lymph node metastases detection 163
Combined 123I-Iofuplane SPECT and 123I-MIBG cardiac scintigraphy use in Parkinson disease(PD) and vascular Parkinsonism(VP) differential diagnosis. 161
The usefulness of SPECT/CT and neck pinhole SPECT (P-SPECT) as complementary tools to planar parathyroid scintigraphy in hyperparathyroidism (HPT). 161
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 159
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 159
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors 158
Neck iodine fixing foci in differentiated thyroid carcinoma (DTC) follow-up patients: a 131 I-SPECT/CT study. 158
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 158
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 157
Beta-endorphin in experimental canine spinal ischemia. 156
The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging 155
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 154
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 154
131I SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC). 150
The classification tree (CIT) classifier applied by 123I-MIBG cardiac scintigraphy in differentiating Parkinson’s disease (PD) from Parkinsonism (P). 150
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 150
123I-MIBG cardiac scintigraphy in discriminating Parkinson’s disease (PD) from vascular Parkinsonism (VP ) using classification tree( CIT ) classifier together with conventional quantitative analysis. 149
123I-MIBG cardiac scintigraphy quantitative analysis in Parkinson’s disease (PD) and Parkinsonisms (P) differential diagnosis: a classification tree (CIT) classifier additional contribute. 149
Brain 18F-FDG PET qualitative and quantitative analyses in Atypical Parkinsonian Syndromes (APS) with Cognitive Clinical Symptoms (CCS) 149
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 149
18F-FDG PET/CT in intracranial leptomeningeal carcinomatosis 148
Beta-endorphin in experimental spinal traumas 147
131I-SPECT/CT usefulness in the follow up of patients thyroidectomized for thyroid papillary microcarcinoma ( PTMC). 147
99mTc-tetrofosmin SPECT/CT in lung lesion detection. 146
Tc 99m-Tetrofosmin scan in lung and breast cancer detection 146
Alterazioni degli indici di funzionalità tiroidea nelle epatopatie croniche. 146
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 146
Alteration in thyrotropin (TSH), Prolactin (PRL) and Growth Hormone (GH) secretions in chronic alcoholism and in liver cirrhosis. 145
Beta-endorphin in experimental spinal traumas 144
Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 144
Behavioral disturbances associated with hyperostosis frontalis interna: a neuroimaging study 144
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 142
Beta-endorphin and cortisol levels in plasma and cerebral fluid (CSP) in experimental spinal cord injury. 142
Alpha-fetoprotein and Hepatitis B Virus infection in chronic liver disease 141
Plasma levels of leptin in heavy obese subjects 141
S-100 protein: a new marker to malignant mela¬noma 141
Alanic transferase, Alphafetoprotein, hepatocellular necrosis and regeneration in chronic liver disease. 140
Caratterizzazione clinica del miocardio ibernato identificato mediante scintigrafia miocardica con Tallio-201. 140
Tc-99m Tetrofosmin (T) scintigraphy in patients with abdominal cancer 138
Beta-Endorphin and cortisol in experimental spinal trauma 138
Breast scintigraphy with a breast specific gamma camera (BSGC) and dynamic breast magnetic resonance imaging (MRI) in the detection of primary breast cancer (BC): A comparative study 137
Free/Total PSA ratio (F/T) and total (T) PSA combined use in monitoring finasteride (F) treated benign prostatic hyperplasia (BPH) 137
131I-SPECT/CT in differentiating neck iodine fixing foci in patients with differentiated thyroid carcinoma (DTC). 137
Beta-Endorphin in Experimental Spinal traumas. 137
Breast-specific imaging (BSGI) in predicting tumor response to treatment and in assessing residual tumor size following neoadjuvant therapy in locally advanced primary breast cancer. 137
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative locl staging of primary breast cancer. 137
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 136
Bone Alkaline Phosphatase (BAP) related to Prostate Specific Antigen (PSA) in bone metastasis prostate cancer (PC) patients 136
Breast scintigraphy with brest specific gammacamera (BSGC) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI ) in local staging and tumor size assessment of primary breast cancer. 135
SPECT/CT with a hybrid imaging system in the study of lower gastrointestinal bleeding with technetium-99m red blood cells 133
99mTc-tetrofosmin planar scintimammography and SPECT in monitoring the response to neoadjuvant hormone or chemotherapy in locally advanced primary breast cancer (LAPBC) 133
Somatostatin receptor scintigraphy (SRS) in the detection of liver metastases from gastroenteropancreatic neuroendocrine tumours (GEP) 133
The use of neck pinhole SPECT in hyperparathyroidism and differentiated thyroid carcinoma 133
Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia 133
The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients 133
Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors 132
Random Forest Classifier contribution in the differential diagnosis of movement disorders studied by 123 I-MIBG cardiac scintigraphy. 132
Non-functioning gastroenteropancreatic (GEP) tumors: a 111In-Pentetreotide SPECT/CT diagnostic study. 132
Totale 17.548
Categoria #
all - tutte 295.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 295.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.196 0 0 0 8 12 13 76 212 219 140 287 1.229
2022/20235.792 708 188 46 997 618 983 16 746 1.016 41 306 127
2023/20241.734 310 143 66 75 394 91 20 40 8 11 153 423
2024/202516.766 105 122 944 184 565 456 1.129 3.853 6.501 1.980 525 402
2025/202622.541 683 6.118 3.064 3.677 1.565 1.049 3.010 841 1.012 794 459 269
2026/20276.635 570 1.740 1.931 2.394 0 0 0 0 0 0 0 0
Totale 71.620